Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- Check3 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed information about a clinical trial for Oropharyngeal Squamous Cell cancers and the addition of new collaborators and a revision number. The principal investigator's name has also been updated.SummaryDifference12%
- Check10 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and has removed a date reference of 2025-03-25 while adding a new date of 2025-01-13.SummaryDifference0.1%
- Check17 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous estimated dates and version. This indicates a significant update to the content.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check53 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.3%
- Check68 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.3%
- Check75 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.